Biphasic and Intermediate Acting Insulins
Insulin (antidiabetic hormone)
What it is used for
Therapeutic use is agent- and indication-specific within the class (Insulin (antidiabetic hormone)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Diabetes mellitus
Warnings
Recognition of early hypoglycaemic signs; reduce dose in renal failure; some patients have reported a loss of warning of hypoglycaemia after transfer from human insulin; beta-blockers; conversion from one type of insulin to another; tolerance to insulin [more common with bovine insulin than with porcine insulin]; close control of blood sugar in pregnancy.
Possible side effects
Hypoglycaemia, weight gain, injection-site reactions, lipodystrophy. Rare: severe allergy, hypokalaemia (shift).
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.